Colosia A, Njue A, Bajwa Z, Dragon E, Robinson RL, Sheffield KM, Thakkar S, Richeimer SH. The burden of metastatic cancer-induced bone pain: a narrative review. J Pain Res. 2022 Oct 25;2022(15):3399-412. doi: 10.2147/JPR.S371337
Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an internet-based survey. J Pain. 2010 Nov 1;11(11):1230-9.
Lewis SA, DeMuro-Mercon CJ, Mordin MM, Farr J, Cole BJ, Mithoefer K, Engelhart L. Measuring pain and function in patients with articular cartilage repair. Poster presented at the 9th World Congress of the International Cartilage Repair Society; September 2010.
Deal LS, DiBenedetti DB, Williams VSL, Fehnel SE. The development and validation of the daily electronic endometriosis pain and bleeding diary. Health Qual Life Outcomes. 2010 Jul 2;8:64.
Johannes C, Le TK, Zhou X, Johnston J, Dworkin R. Treatment seeking behavior of adults with chronic lower back pain and chronic osteoarthritis pain: descriptive results from a population survey. Poster presented at the 29th Annual Scientific Meeting of the American Pain Society; May 2010.
Solidaki E, Chatzi L, Bitsios P, Markatzi I, Plana E, Castro F. Work-related and psychological determinants of multisite musculoskeletal pain. Scand J Work Environ Health. 2010 Jan;36(1):54-61.
Williams VS, Smith MY, Fehnel SE. The validity and utility of bpi interference measures addressing the impact of pain. Poster presented at the Annual International Society for Quality of Life Research (ISOQOL) Conference; November 2003.
Allen RM, Granger AL, Dykstra LA. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. J Pharmacol Exp Ther. 2003 Nov 1;307(2):785-92.
Ackerman SJ, Mordin M, Reblando J, Xu X, Schein J, Vallow S, Brennan M. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain. J Manag Care Pharm. 2003 May 1;9(3):223-31.
Sánchez Matienzo D, Gimeno V, Castellsague J, Arana A. Safety profile of smell and taste disorders in patients treated with cox-2 specific inhibitors and other selected drugs. Presented at the 19th International Conference on Pharmacoepidemiology; 2003.
Rothman KJ, Wepsic JG. Side of facial pain in trigeminal neuralgia. J Neurosurg. 1974 Jan 1;40(4):514-6.